Risk Register
Risk Register — Rashi Peripherals Ltd (RASHIPERIP)
Risk Dashboard
Total Risks Tracked
Active Risks
Critical Impact Risks
High Prob × Critical Impact
Tripwires ≤90 Days
Active Risk Register
Top 5 Risks
1. Win10/ASP Margin Reversion
High Probability × Critical Impact. Q1 FY27 EBITDA printing below 2.3% without Win10 or large-project support would force consensus resets and multiple compression toward 10.5x, implying a bear price of ₹335 (-37% from current ₹530.60).
The single most consequential risk in the register. Rashi's Q3 FY26 EBITDA margin of 2.95% — the highest in its four-year listed history — rested on three simultaneous tailwinds that are now substantially exhausted: Windows 10 end-of-life demand (cycle ended October 2025), laptop ASP inflation of 20–30%, and RAM/SSD price increases of 2–3×. Management confirmed in the Q3 FY26 earnings call that tertiary demand (actual consumer purchases) lagged channel stocking, meaning a portion of FY26 revenue reflects pull-forward rather than new structural end-user demand. The underlying EBITDA compression trend from 3.41% in FY2021 to 2.62% in FY2025 has no structural reason to reverse absent the Dell ramp and operating leverage; if it reasserts, FY27E PAT compresses toward ₹210 Cr. Additionally, Crucial by Micron was discontinued in April 2026, removing a component revenue stream management itself described as a "dent." Each 50 bps of sustained margin expansion on ₹14,000 Cr revenue equals ₹70 Cr incremental EBITDA — symmetrically, a 50 bps compression equals ₹70 Cr loss. The first clean read on FY27 trajectory will come from Q1 FY27 results in mid-July 2026; a print below 2.3% falsifies the structural leverage thesis and makes the bear scenario the modal outcome. Sources: Stan/Bear thesis (verdict-claude.md), Business (business-claude.md), Scenarios (scenarios-claude.md).
2. Structural Negative OCF
High Probability × Critical Impact. Five consecutive years of negative operating cash flow (cumulative -₹10,408 Mn vs NI +₹7,851 Mn FY21–25) means 14.4× P/E is priced on earnings that have never materialized as cash. At 9M FY26's ₹34 Cr positive OCF rate, it would take approximately 40 years to convert one year of PAT into cash.
Rashi's forensic grade is Elevated (42/100), driven primarily by this structural cash-generation failure. Short-term bank debt grew 98% from ₹4,899 Mn to ₹9,696 Mn over four years as debt funded the gap between reported earnings and actual cash generation. The 3-year CFO/NI ratio of -1.09× is the most damning single metric: it means every rupee of reported net income destroyed more than one rupee of operating cash. The one positive data point — 9M FY26 OCF of ₹34 Cr — is the first measurable positive in the company's listed history, but ₹34 Cr on ₹14,000+ Cr TTM revenue is a rounding error and does not constitute an inflection. CRISIL's AA- upgrade (September 2025) validates lender comfort with the current structure but does not change the cash conversion reality — lenders are secured by collateral and receivables, not unlevered FCF. The verdict changes from "Lean Long, Wait For Confirmation" to outright Lean Long only if FY26 full-year OCF confirms above ₹200 Cr (May 14 results provide the first full-year read). Sources: Stan/Bear thesis (verdict-claude.md), Forensics (forensics-claude.md), Numbers (numbers-claude.md).
3. Other Income ₹606 Mn Unconfirmed
High Probability × High Impact. FY2025 other income of ₹606 Mn was 321% above the prior year with no line-item breakdown in the annual report. Forensics estimates this inflated reported PAT by up to ₹494 Mn — approximately 24% of FY2025's ₹2,076 Mn reported PAT. If material portions are non-recurring, normalized FY2025 EBITDA margin was approximately 2.3–2.4%, not the 2.62% reported.
The other income composition remains unverifiable until the FY2026 Annual Report (expected September–October 2026). If the ₹606 Mn includes non-recurring items — insurance claims, asset disposals, or one-time rebate true-ups — then FY2025 earnings are overstated and Q3 FY26's comparison base is weaker than reported. The forensics tab flags that management has not disclosed a breakdown despite the magnitude of the jump, and the research tab notes Exencial Research's January 2026 report flagged manual rebate accounting as the highest single forensic risk post-IPO. This risk is distinct from the Win10 reversion risk: even if EBITDA margins hold structurally, if other income normalizes downward, reported PAT declines without any operational deterioration. Sources: Forensics (forensics-claude.md), Catalysts (catalysts-claude.md), Research (research-claude.md).
4. Redington GPU/CPU Dual-Authorization
The single binary event that can permanently impair Rashi's competitive position. Rashi holds approximately 47% of India GPU distribution and 45% of CPU distribution (Technopak 2023), generating a 35–49 bps EBITDA margin premium over Redington on near-identical gross margins. These OEM authorizations are explicitly non-exclusive per Rashi's own FY2025 Annual Report. If Redington receives NVIDIA GPU or Intel CPU dual-authorization, Rashi's market-funding development (MDF) rebate advantage collapses within 2–4 quarters as volume shifts. Redington's superior ROCE of 21% vs Rashi's 13.1% means Redington can offer channel partners longer credit terms and larger stocking agreements at rates Rashi cannot match without destroying returns. This is classified as Latent rather than Active because no dual-authorization announcement has occurred; it is Medium probability because Redington already holds 430+ brand relationships vs Rashi's 70 and has the balance sheet to absorb the investment. The scenarios tab identifies this as the single risk that immediately kills the bull case regardless of revenue and margin trajectory. Sources: Moat (moat-claude.md), Competition (competition-claude.md), Stan/Bear (verdict-claude.md).
5. Working Capital / Receivables Quality
Working capital days rose from 54 days in FY2025 to 61 days in H1 FY26, adding approximately ₹190 Cr of incremental cash absorption for each 5-day extension on ₹13,773 Cr of FY2025 revenue. The forensics tab identified a FY2024 receivables spike of +58.8% against revenue growth of only +17.4% — a divergence that was never explained by management. Debtor ageing schedules are not disclosed in annual reports, preventing independent verification of receivables quality. Net Debt stands at ₹948 Cr with Net Debt/EBITDA of approximately 2.8×. A meaningful deterioration in receivables quality — for example, if channel partners who over-stocked in Q3 FY26 are slow to pay — could push working capital days above 70 and force additional short-term borrowing at rates that further suppress already-thin margins. Q4 FY26 results on May 14 provide the next WCD and DSO data point. Sources: Forensics (forensics-claude.md), Numbers (numbers-claude.md).
Dormant and Latent Risks
Risk Mitigants
How the Risk Profile Has Changed
The overall risk posture has shifted from Moderate to Elevated over the twelve months to May 2026, driven by two developments in opposite directions. On the positive side, CRISIL's double upgrade to AA-/Stable and A1+ (September 2025) and the Dell distribution authorization (August 2025) represent the two most consequential risk-reducing events in Rashi's listed history: the credit upgrade materially reduces refinancing risk on ₹9,696 Mn of short-term borrowings, and Dell introduces a revenue diversification wedge that could structurally improve operating leverage from FY27. On the negative side, three KMP exits in twelve months (CFO March 2025, Company Secretary and Compliance Officer November 2025), an unexplained ₹606 Mn other income jump in FY2025, an Exencial Research report in January 2026 flagging manual rebate accounting, and two promoter-linked related-party events — the Satcom Infotech deal (announced January 2025, then formally terminated per Q4 FY2025 earnings call) and the completed RP Tech Electronics acquisition (April 2026 for ₹10 Cr) — have raised governance risk to the highest level in the company's post-IPO history. The net effect is that the risk distribution has widened: the tail risks on both ends have grown larger, which is why the probability-weighted expected value of ₹590 sits above the current price but the bear scenario commands 30% probability mass with a 37% drawdown.
The most important risk event in the next 90 days is Q4 FY26 results on May 14, 2026. EBITDA margin above 2.7% and positive OCF move the register's two highest-ranked risks from Active to Mitigated; EBITDA below 2.3% and negative OCF confirm both risks are fully crystallizing.
The governance risk cluster (Risks 3, 8, 9, 10) is partially self-resolving: the FY2026 Annual Report (expected September–October 2026) will disclose other income composition, auditor findings, and updated RPT schedules, providing the most comprehensive governance read since IPO.
Tripwire Calendar
The May 14, 2026 Q4 FY26 results are the single most information-dense event in the next 90 days, providing simultaneous reads on the four highest-ranked risks in this register; the verdict on Rashi Peripherals as an investment is substantially determined by whether EBITDA margin in that print is above or below 2.5%.